Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
NCT07570121
Pharmacokinetics and Placental Transfer of CaffeineIndiana Clinical and Translational Sciences InstituteNot Yet RecruitingPhase 1
NCT07570121Not Yet Recruiting
Phase 1
Pharmacokinetics and Placental Transfer of CaffeineIndiana Clinical and Tran...
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07571512
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Knee Arthroplasty for the Study of Innovative Solutions in the Treatment of Joint and Ligament PathologiesStefano ZaffagniniCompleted
NCT07571512Completed
—
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Kn...Stefano Zaffagnini
NCT07569835
Clinical and Radiological Evaluation Over 10 Years After Bilateral Subtalar Arthrorisis Surgery With Endorthesis and Calcaneal Stop for the Correction of Pediatric FlatfootIstituto Ortopedico RizzoliRecruiting
NCT07569835Recruiting
—
Clinical and Radiological Evaluation Over 10 Years After Bilateral Subtalar Arth...Istituto Ortopedico Rizzo...
NCT07570524
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene MarquisNot Yet Recruiting
NCT07570524Not Yet Recruiting
—
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene Marquis
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07569029
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesDepartment of Health and Human Services (HHS)Not Yet RecruitingPhase 1
NCT07569029Not Yet Recruiting
Phase 1
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA...Department of Health and...
NCT07568600
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hyaluronate Carbomer Composite HydrogelThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07568600Not Yet Recruiting
Not Applicable
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hy...The First Affiliated Hosp...
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571252
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto RicoNot Yet RecruitingPhase 4
NCT07571252Not Yet Recruiting
Phase 4
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto Rico
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07569055
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Guangxi Medical UniversityRecruiting
NCT07569055Recruiting
—
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoie...First Affiliated Hospital...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569224
Testing the Impact of the MOHR Follow-up SupportNational Cancer Institute (NCI)RecruitingNot Applicable
NCT07569224Recruiting
Not Applicable
Testing the Impact of the MOHR Follow-up SupportNational Cancer Institute...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07568834
Impact of Pelvic Pain PodcastVanderbilt University Medical CenterRecruitingNot Applicable
Result Breakdown
Not yet recruiting11 (55%)
Recruiting8 (40%)
Completed1 (5%)
not_applicable7 (35%)
Not Specified6 (30%)
Phase 14 (20%)
Phase 42 (10%)
Phase 21 (5%)